Orthofix is realigning its spine business unit effective March 1, and the company named Jason Shallenberger as president of the bone growth therapies business.
Spinal Tech
Spineart completed enrollment for the U.S. investigational device exemption trial with the Baguera C cervical disc implant, the devicemaker said Feb. 29.
Woven Orthopedics earned its second FDA 510(k) clearance for the Ogmed implantable sleeve, the company said Feb. 29.
ZimVie posted spine sales decreases in the fourth quarter and full year ahead of its planned sale of the business segment.
Nevro earned FDA 510(k) clearance to use its sacroiliac joint fixation system without having to include a lateral screw, the devicemaker said Feb. 28.
Advertisement
Here are four key developments from spine and orthopedic devicemakers since Feb. 21.
Alphatec CEO Pat Miles has big expectations for the company after a strong 2023.
Medtech company Smith+Nephew surpassed $5 billion in 2023 revenue, according to its Feb. 27 financial report.
Spine devicemaker SI-Bone saw $138.9 million in revenue in 2023, the company said Feb. 26.
Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering, the company said Feb. 26.